[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40862-40863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16162]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; IMAT Biospecimen Research.
    Date: September 30, 2021.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460, 
<a href="/cdn-cgi/l/email-protection#036965626d64436e626a6f2d6d6a6b2d646c75"><span class="__cf_email__" data-cfemail="5c363a3d323b1c313d353072323534723b332a">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
    Date: October 20-21, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Rockville, Maryland 20850, 240-276-7286, 
<a href="/cdn-cgi/l/email-protection#2e5d4f42585b4d4d416e434f47420040474600494158"><span class="__cf_email__" data-cfemail="aeddcfc2d8dbcdcdc1eec3cfc7c280c0c7c680c9c1d8">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Initial Review 
Group; Transition to Independence Study Section (I).
    Date: October 20-21, 2021.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456, 
<a href="/cdn-cgi/l/email-protection#186c79767f7c587579717436767170367f776e"><span class="__cf_email__" data-cfemail="99edf8f7fefdd9f4f8f0f5b7f7f0f1b7fef6ef">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-3: NCI Clinical and Translational Cancer Research.
    Date: October 21-22, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Rockville, Maryland 20850, 
<a href="/cdn-cgi/l/email-protection#62110a170e0b4c1a0b03220c0b0a4c050d14"><span class="__cf_email__" data-cfemail="35465d40595c1b4d5c54755b5c5d1b525a43">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
    Date: November 4-5, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Susan Lynn Spence, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850, 
<a href="/cdn-cgi/l/email-protection#13606660727d3d6063767d7076537d7a7b3d747c65"><span class="__cf_email__" data-cfemail="1f6c6a6c7e71316c6f7a717c7a5f71767731787069">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
    Date: November 4-5, 2021.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-276-7975, 
<a href="/cdn-cgi/l/email-protection#02616a7764636c6767426f636b6e2c6c6b6a2c656d74"><span class="__cf_email__" data-cfemail="e182899487808f8484a18c80888dcf8f8889cf868e97">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 40863]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: July 26, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16162 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>